These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 35372904)

  • 1. Immune Checkpoint Inhibitor Nephrotoxicity: Update 2020.
    Gupta S; Cortazar FB; Riella LV; Leaf DE
    Kidney360; 2020 Feb; 1(2):130-140. PubMed ID: 35372904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute kidney injury associated with immune checkpoint inhibitor therapy: incidence, risk factors and outcomes.
    Meraz-Muñoz A; Amir E; Ng P; Avila-Casado C; Ragobar C; Chan C; Kim J; Wald R; Kitchlu A
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32601079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune checkpoints inhibitors and its link to acute kidney injury and renal prognosis.
    Kanbay M; Yildiz AB; Siriopol D; Vehbi S; Hasbal NB; Kesgin YE; Celayir M; Selcukbiricik F; Covic A; Perazella MA
    Int Urol Nephrol; 2023 Apr; 55(4):1025-1032. PubMed ID: 36282399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute kidney injury in patients treated with immune checkpoint inhibitors.
    Gupta S; Short SAP; Sise ME; Prosek JM; Madhavan SM; Soler MJ; Ostermann M; Herrmann SM; Abudayyeh A; Anand S; Glezerman I; Motwani SS; Murakami N; Wanchoo R; Ortiz-Melo DI; Rashidi A; Sprangers B; Aggarwal V; Malik AB; Loew S; Carlos CA; Chang WT; Beckerman P; Mithani Z; Shah CV; Renaghan AD; Seigneux S; Campedel L; Kitchlu A; Shin DS; Rangarajan S; Deshpande P; Coppock G; Eijgelsheim M; Seethapathy H; Lee MD; Strohbehn IA; Owen DH; Husain M; Garcia-Carro C; Bermejo S; Lumlertgul N; Seylanova N; Flanders L; Isik B; Mamlouk O; Lin JS; Garcia P; Kaghazchi A; Khanin Y; Kansal SK; Wauters E; Chandra S; Schmidt-Ott KM; Hsu RK; Tio MC; Sarvode Mothi S; Singh H; Schrag D; Jhaveri KD; Reynolds KL; Cortazar FB; Leaf DE;
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34625513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune checkpoint inhibitors and acute kidney injury.
    Zhou P; Gao Y; Kong Z; Wang J; Si S; Han W; Li J; Lv Z; Wang R
    Front Immunol; 2024; 15():1353339. PubMed ID: 38464524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute kidney injury in patients receiving immune checkpoint inhibitors: a retrospective real-world study.
    Lumlertgul N; Vassallo P; Tydeman F; Lewis N; Hobill A; Weerapolchai K; Nordin NZ; Seylanova N; Martin L; Cennamo A; Wang Y; Rigg A; Shaunak N; Ostermann M
    Eur J Cancer; 2023 Sep; 191():112967. PubMed ID: 37499561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and risk factors of acute kidney injury, and its effect on mortality among Japanese patients receiving immune check point inhibitors: a single-center observational study.
    Shimamura Y; Watanabe S; Maeda T; Abe K; Ogawa Y; Takizawa H
    Clin Exp Nephrol; 2021 May; 25(5):479-487. PubMed ID: 33471239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute Interstitial Nephritis and Checkpoint Inhibitor Therapy: Single Center Experience of Management and Drug Rechallenge.
    Manohar S; Ghamrawi R; Chengappa M; Goksu BNB; Kottschade L; Finnes H; Dronca R; Leventakos K; Herrmann J; Herrmann SM
    Kidney360; 2020 Jan; 1(1):16-24. PubMed ID: 35372854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological features of kidney injury in patients receiving immune checkpoint inhibitors (ICPi) combined with anti-vascular endothelial growth factor (anti-VEGF) therapy.
    Jin S; Shen Z; Li J; Liu X; Zhu Q; Li F; Shi Y; Lin P; Xu X; Chen X; Geng X; Ding X; Liu H
    J Clin Pathol; 2024 Jun; 77(7):471-477. PubMed ID: 38242556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI.
    Gupta S; Garcia-Carro C; Prosek JM; Glezerman I; Herrmann SM; Garcia P; Abudayyeh A; Lumlertgul N; Malik AB; Loew S; Beckerman P; Renaghan AD; Carlos CA; Rashidi A; Mithani Z; Deshpande P; Rangarajan S; Shah CV; Seigneux S; Campedel L; Kitchlu A; Shin DS; Coppock G; Ortiz-Melo DI; Sprangers B; Aggarwal V; Benesova K; Wanchoo R; Murakami N; Cortazar FB; Reynolds KL; Sise ME; Soler MJ; Leaf DE;
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36137651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying Patients at Risk of Acute Kidney Injury among Patients Receiving Immune Checkpoint Inhibitors: A Machine Learning Approach.
    Yu X; Wu R; Ji Y; Huang M; Feng Z
    Diagnostics (Basel); 2022 Dec; 12(12):. PubMed ID: 36553164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study.
    Cortazar FB; Kibbelaar ZA; Glezerman IG; Abudayyeh A; Mamlouk O; Motwani SS; Murakami N; Herrmann SM; Manohar S; Shirali AC; Kitchlu A; Shirazian S; Assal A; Vijayan A; Renaghan AD; Ortiz-Melo DI; Rangarajan S; Malik AB; Hogan JJ; Dinh AR; Shin DS; Marrone KA; Mithani Z; Johnson DB; Hosseini A; Uprety D; Sharma S; Gupta S; Reynolds KL; Sise ME; Leaf DE
    J Am Soc Nephrol; 2020 Feb; 31(2):435-446. PubMed ID: 31896554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal adverse effects of immune checkpoints inhibitors in clinical practice: ImmuNoTox study.
    Espi M; Teuma C; Novel-Catin E; Maillet D; Souquet PJ; Dalle S; Koppe L; Fouque D
    Eur J Cancer; 2021 Apr; 147():29-39. PubMed ID: 33607383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?
    Franzin R; Netti GS; Spadaccino F; Porta C; Gesualdo L; Stallone G; Castellano G; Ranieri E
    Front Immunol; 2020; 11():574271. PubMed ID: 33162990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Proton Pump Inhibitor Use and Immune Checkpoint Inhibitor-Mediated Acute Kidney Injury: A Meta-Analysis and a Review of Related Outcomes.
    Mohan A; Krisanapan P; Tangpanithandee S; Thongprayoon C; Kanduri SR; Cheungpasitporn W; Herrmann SM
    Am J Nephrol; 2024; 55(4):439-449. PubMed ID: 38471492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors.
    Cortazar FB; Marrone KA; Troxell ML; Ralto KM; Hoenig MP; Brahmer JR; Le DT; Lipson EJ; Glezerman IG; Wolchok J; Cornell LD; Feldman P; Stokes MB; Zapata SA; Hodi FS; Ott PA; Yamashita M; Leaf DE
    Kidney Int; 2016 Sep; 90(3):638-47. PubMed ID: 27282937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors.
    Seethapathy H; Zhao S; Chute DF; Zubiri L; Oppong Y; Strohbehn I; Cortazar FB; Leaf DE; Mooradian MJ; Villani AC; Sullivan RJ; Reynolds K; Sise ME
    Clin J Am Soc Nephrol; 2019 Dec; 14(12):1692-1700. PubMed ID: 31672794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with immune check point inhibitors and acute kidney injury.
    Valentin A; Møller AKH; Palshof JA; Broberg B; Gravesen E; Svane IM; Hansen D
    Acta Oncol; 2023 Feb; 62(2):121-125. PubMed ID: 36755491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune checkpoint inhibitor-associated acute kidney injury and mortality: An observational study.
    Koks MS; Ocak G; Suelmann BBM; Hulsbergen-Veelken CAR; Haitjema S; Vianen ME; Verhaar MC; Kaasjager KAH; Khairoun M
    PLoS One; 2021; 16(6):e0252978. PubMed ID: 34101756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single and combination immunotherapy with chemotherapy and the risk of AKI in patients with solid cancer.
    de Brito GA; Junior APN; Silva MBE; Bettim BB; Pereira BJ
    Clin Exp Nephrol; 2024 Apr; 28(4):273-281. PubMed ID: 37995062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.